Risk of malignant melanoma in relation to drug intake, alcohol, smoking and hormonal factors J Westerdahl', H Olsson2, A Masback3, C Ingvar' and N Jonsson3 Departments of 'Surgery, 2Oncology, 3Pathology, University Hospital, S-22J85 Lund, Sweden.
Most studies of risk factors for developing malignant melanoma have focused on sun exposure and constitutional factors. The evidence relating cutaneous melanoma to sunlight is now very strong, however, the association seems to be complex (Elwood, 1992) . It is therefore possible that other factors could act as co-carcinogenes with sunlight. In addition, other factors may by themselves initiate or promote melanoma development.
It is known that a variety of chemical substances including medicaments of quite different categories (e.g. antibiotics, psychotropic drugs, etc.) have affinity for melanin (Larsson, 1993) and that many commonly used drugs may increase the sensitivity of our skin to sunlight (Allen, 1993) . However, to date there exists in the epidemiological literature no study of melanoma risk associated with use of prescribed drugs.
The role of alcohol intake has been investigated in several epidemiological studies, but the results so far are inconsistent. In four studies an association between alcohol intake and increased risk of melanoma has been reported (Williams and Horm, 1977; Holman et al., 1986; Stryker et al., 1990; Bain et al., 1993) , while in an additional study an inverse relation has been demonstrated (0sterlind et al., 1988a) . In three other studies no consistent association between alcohol consumption and melanoma risk has been shown (Green et al., 1986; Adami et al., 1992; Kirkpatrick et al., 1994) . Furthermore, tobacco smoking has been evaluated as a risk factor, but it has not been found to influence melanoma risk significantly (Williams and Horm, 1977; Paffenberger et al., 1978; Green et al., 1986; Holman et al., 1986; 0sterlind et al., 1988a) .
There has also been a continued interest in the association between sexual hormones (exogenous and/or endogenous) in females and malignant melanoma, but the results have been predominantly negative (Beral et al., 1977; Adam et al., 1981; Bain et al., 1982; Helmrich et al., 1984; Holman et al., 1984; Green and Bain, 1985; Osterlind et al., 1988b; Hannaford et al., 1991; Palmer et al., 1992) . However, there have been some significantly elevated odds ratios for long duration of oral contraceptive use (Holly et al., 1983; Beral et al., 1984; Le et al., 1992) and for assorted menstrual and reproductive factors (Holly et al., 1983; Gallagher et al., 1985; Zanetti et al., 1990; Le et al., 1992) . It is noteworthy that each of the individual menstrual and reproductive variables have been considered only in relatively few studies.
We have conducted a population-based, matched casecontrol study of malignant melanoma in the South Swedish Health Care Region. The influence of sunlight, use of sunbeds or sunlamps, sunscreen use and constitutional factors on melanoma risk have been previously reported (Westerdahl et al., 1994a (Westerdahl et al., ,b, 1995 . We report here on the risk of developing malignant melanoma in relation to use of prescribed drugs, alcohol intake, smoking habits, and reproductive and hormonal factors.
Materials and methods
Detailed descriptions of identification of cases and controls, as well as data collection have been reported in previous reports (Westerdahl et al., 1994a,b six patients presenting with metastatic melanoma and seven patients whose original diagnosis could not be re-examined (348 cases and 562 controls)-re-examined material. In addition, analyses were also carried out on all cases with a first diagnosis of malignant melanoma, (according to the Tumour Registry), who had answered the questionnaire and also had at least one matched control (400 cases and 640 controls)-original material. Odds ratios (ORs) were computed, based on matched pairs, using both univariate and multivariate methods. In the multivariate analyses conditional logistic regression was used. The multivariate models included adjustments for hair colour (red, blond/fair, other), number of raised naevi (none, 1-3, >3) and number of sunburns (none, 1 -2, > 3), which were important risk factors identified in this case -control study (Westerdahl et al., 1994a (Westerdahl et al., , 1995 . A P-value of less than 0.05 were considered significant and 95% confidence intervals (CIs) were used. The statistical program Stata was used (Computing Resource Center, Santa Monica, CA, USA). Occasional missing values for some variables caused slight variation in the numbers of cases and controls used for each analysis. This study had a power of 86% in finding an odds ratio of 1.7, given that 10% of controls were exposed, two controls per case, 400 cases and a P-value of 0.05.
This study was approved by the Ethical Committee of the Medical Faculty of Lund University. Informed consent was sought from the treating physician, the patient and the healthy control.
Results

Re-examined material
In an analysis of different categories of drugs (antihypertensive drugs, drugs used for various heart diseases, antimicrobial drugs, tranquillisers, endocrine drugs and other drugs), only use of antihypertensive agents showed an elevated OR for melanoma development (OR = 1.3, 95% CI 1.0-1.9 for use of at least 1 month vs no use). When females and males were considered separately, use of antihypertensive drugs and tranquillisers respectively, were associated with melanoma in males (OR = 1.6, 95% CI 1.0-2.8 and OR = 2.2, 95% CI 1.0-5.7 respectively) whereas among females no elevated ORs were found. Adjusting for history of sunburns, hair colour and number of raised naevi had a negligible effect on the risk estimates for antihypertensive drug use (adjusted OR Drugs, alcohol, smoking, hormones and melanoma J Westerdahl et al = 1.3, 95% CI 1.0-1.9 for both gender and adjusted OR = 1.6, 95% CI 1.0-2.9 for men). However, the elevated OR among men for use of tranquillisers was essentially the same after adjustments for history of sunburns, but became nonsignificant after host factors (hair colour and/or raised naevi) also were taken into account (adjusted OR = 1.8, 95% CI 0.7-4.8).
In Table I analyses restricted to specific types of commonly used antihypertensive drugs and tranquillisers are shown. As can be seen, use of beta-blockers was associated with melanoma development (adjusted OR = 1.7, 95% CI 1.0-2.7 for use of at least 1 month vs no use). The relation between use of benzodiazepines and melanoma was, in the same manner as described above (for use of tranquillisers), diminished in adjusted analyses. No sexspecific analyses were performed owing to small numbers. Use of hydralazines showed also an association with melanoma (P <0.01), however, it was not possible to calculate OR and CI owing to no exposed controls. There were no significant correlations between any of the specific types of drugs and the host factors used in the conditional logistic regression model in Table I .
Both among cases and among controls 83% were found to ever consume alcohol. Intake of any alcoholic beverage was not related to melanoma development (adjusted OR = 1.0, 95% CI 0.7-1.4 for any alcohol intake vs no alcohol intake). An elevated OR for development of melanoma was found with frequent intake of distilled liquor (adjusted OR = 1.4, 95% CI 1.0-1.9 for more than once a month vs less than once a month). However, no association was found between risk of melanoma and frequent intake of either wine, beer or light beer (data not shown). Total alcohol intake (g day-') was not related with melanoma risk (Table II) , nor was alcohol intake categorised as light beer, beer, wine or distilled liquor (data not shown). Virtually the same ORs were seen when men and women were considered separately. The same was true for individuals younger than age 50 years and older than age 50 years respectively.
No significant relation between tobacco smoking and malignant melanoma was found (adjusted OR = 0.9, 95% CI 0.7-1.2 for ever smoker vs never smoker) (Table II) . A total of 52% of the cases and 57% of the controls reported ever smoking. Essentially the same results were seen in sexspecific analyses. Analyses on endogenous and exogenous hormonal exposure were performed on 180 female cases and 292 female controls.
Neither age at menarche nor age at menopause were related to risk of developing melanoma (data not shown). A total of 45% of cases and controls respectively were premenopausal. The OR for developing malignant melanoma after ever being pregnant was 0.8 (95% CI 0.4-1.5), adjusted for history of sunburns, hair colour and number of raised naevi. The relation between other reproductive factors and melanoma risk is shown in Table III . Whereas no association was found with either age at first child or number of pregnancies, there was a significant trend of decreasing risk with increasing number of children (P = 0.01). The estimated ORs were unaffected by educational level. Number of stillbirths or number of miscarriages were not recorded.
Use of oral contraceptives was not related to melanoma development. Among cases 40% and among controls 37% reported ever using oral contraceptives (adjusted OR = 1.6, 95% CI 0.9-2.8 for ever used oral contraceptives vs never). The duration of use (Table III) , age at first use or age at latest use were not associated with melanoma development. No association between the timing of taking oral contraceptives in relation to first child (number of years before or after) and risk of melanoma was found. We found ORs for oral contraceptive use to be virtually the same when the study was restricted to those most likely to have used them-women aged 20-60 years.
A total of 13% of cases and 14% of controls had ever used menopausal replacement therapy, and the adjusted OR for developing malignant melanoma after ever having used menopausal replacement therapy was 1.0 (95% CI 0.5 -1.8).
As for oral contraceptives, no associations were found between melanoma and duration of menopausal replacement therapy use, age at first use or age at latest use.
When reproductive and hormonal factors were considered in site-specific analyses (melanoma of the trunk compared vs the extremity or head and neck) the results did not differ from the overall results.
Among other factors studied, blood transfusion was not significantly associated with subsequent melanoma development (OR= 1.2, 95% CI 0.8-1.9 for any prior blood transfusion vs none).
Original material When all the analyses were performed on all cases with a first histopathological diagnosis of malignant melanoma (according to the Tumour Registry) who had answered the questionnaire and also had at least one matched control, the ORs did not essentially differ from those reported above. However, among prescribed drugs use of beta-blockers were, in the same manner as described above for use of tranquillisers, not significantly associated with melanoma development when adjustments for constitutional factors were performed (adjusted OR = 1.5, 95% CI 0.9-2.3 for use of at least one month continuously vs no use). Analyses on endogenous and exogenous hormonal exposure were performed on 205 female cases and 327 female controls.
Discussion
The aim of this report was to present data on melanoma risk according to use of commonly prescribed drugs, alcohol intake, smoking habits and reproductive and hormonal factors. Analyses were carried out both on histopathologically reviewed (re-examined material) and non-re-examined material (original material) Interestingly, use of beta-blockers and benzodiazepines respectively showed elevated ORs for melanoma developDrugs, alcohol, smoking, hormones and melanoma J Westerdahl et al % 1129 ment. However, our data on prescribed drugs were based on ever use, before diagnosis/interview, for more than a month continuously, and no information was available regarding dosage, age at first use, time since last use and total lifetime exposure. Thus, non-differential misclassification (i.e. measurement error that is independent of disease status) of drug exposure may to some degree have been present but the effect of this error would rather have been to bias our measure of association toward the null value. We have no reason to believe that the data on drug use differ between cases and controls since neither group could have been aware of the hypothesis. The associations were virtually the same after adjustments for sunburns but were attenuated and, at least for benzodiazepines, non-significant when constitutional factors were also taken into account. Thus, the association between use of benzodiazepines and risk of melanoma seems to have been generated by confounding with constitutional factors. However, there was no a priori reason to suspect that host factors would confound a relation between use of prescribed drugs and melanoma. Host factors were considered confounders, and therefore included in the analyses, only because they have been identified as independent risk factors (Westerdahl et al., 1995) . It may also be argued that the analyses should not be adjusted for constitutional factors as there is a possibility that they may be part of the causal pathway and thus not true confounders.
Use of hydralazines also showed an association with melanoma.
The reason(s) for our results is(are) unknown. If the results represent true relations, there may exist biologically possible explanations, as it is known that a variety of drugs have affinity for melanin (Larsson, 1993) and that melanocytes contain bioactivating enzymes (Agarwal et al., 1991) . Furthermore, many commonly prescribed drugs increase the sensitivity of our skin to sunlight (Hawk, 1990; Allen, 1993) . However, it is also possible that the elevated ORs may be due to chance because of the multiple testing in our study. Still another possibility would be that such associations reflect frequency of contact with medical care, and thus diagnostic opportunity. However, oral contraceptive users as well as other prescribed drug users also have contact with the health care system on a regular basis but we found no elevated ORs for melanoma among them. Whether our results on beta-blockers and benzodiazepines may be due to chance, generated by confounding or represent true findings need to be further investigated. In the epidemiological literature almost no attention has been paid to a possible association between pharmaceutical drugs and melanoma. So far, only a few studies have briefly mentioned negative results without displaying data (Beral et al., 1988; Adam et al., 1981; Green et al., 1986) .
It has been hypothesised that melanoma development may be promoted by alcohol-induced pituitary secretion of melanocyte-stimulating hormone (Williams, 1976) . Several studies have therefore investigated the association between alcohol and melanoma (Williams and Horm, 1977; Green et al., 1986; Holman et al., 1986; 0sterlind et al., 1988a; Stryker et al., 1990; Adami et al., 1992; Bain et al., 1993; Kirkpatrick et al., 1994) . A positive relation has been reported in four studies (William and Horm, 1977; Holman et al., 1986; Stryker et al., 1990; Bain et al., 1993) . In a case -control study based on the Third National Cancer Survey, a non-significant positive association between alcohol and melanoma was demonstrated (William and Horm, 1977 significant. Except for the latter study none of these positive studies have adequately considered sun exposure as a possible confounder. In contrast, a study by 0sterlind et al. (1988a) demonstrated a significant trend for decreasing melanoma risk with increasing alcohol intake. In our study we found no elevated ORs for developing malignant melanoma according to either total alcohol intake or alcohol intake categorised as light beer, beer, wine and distilled liquor. Furthermore, no variations by sex or age were demonstrated. In the present study we did control for sun exposure; however, the results were unchanged. Our findings are in accordance with the results from several other studies (Green et al., 1986; Adami et al., 1992; Kirkpatrick et al., 1994) . Therefore, when considering all available data together it seems unlikely that alcohol intake is an independent risk factor for melanoma.
In accordance with previous findings (Williams and Horm, 1977; Paffenberger et al., 1978; Green et al., 1986; Holman et al., 1986; 0sterlind et al., 1988a) , smoking did not seem to significantly influence melanoma risk.
Since it has been oberved that endogenous female hormones might influence melanoma incidence (Boyle and Robertson, 1987) and prognosis (Holly, 1986) , and that hyperpigmentation occurs during pregnancy and oral contraceptive use (Sanchez et al., 1981) , it has been hypothesised that there could be an association between sexual hormones (endogenous and/or exogenous) and melanoma development in female. Several studies have therefore, in addition to the results reported on oral contraceptives, to a varying extent also investigated menstrual and reproductive factors (Holly et al., 1983; Holman et al., 1984; Gallagher et al., 1985; Green and Bain, 1985; Osterlind et al., 1988b; Zanetti et al., 1990; Hannaford et al., 1991; Le et al., 1992) . Like Gallagher et al. (1985) we found support for a decrease in melanoma risk (a significant trend) for women with greater number of live births. In an Italian study an inverse association between number of live births and melanoma was found to be diminished by adjustment for education, sun exposure and sun susceptibility (Zanetti et al., 1990) . Gallagher et al. (1985) did not take sun exposure into account in their analyses. Six other studies have reported on this issue (Holly et al., 1983; Holman et al., 1984; Green and Bain, 1985; 0sterlind et al., 1988b; Hannaford et al., 1991; Le et al., 1992) , and four of them have shown a non-significantly decreased risk (Holly et al., 1983; Holman et al., 1984; Osterlind et al., 1988b; Hannaford et al., 1991) . Holly et al. (1983) demonstrated delayed childbearing to be related to increased melanoma risk. This was true only for superficial spreading melanoma and in the analysis only adjustments for oral contraceptive use and education were done. In a recent study menarche before age 14 years was suggested to be associated with melanoma risk (Le et al., 1992) . As have others (Holman et al., 1984; Gallagher et al., 1985; Green and Bain, 1985; 0sterlind et al., 1988b) , we found no evidence of a significant effect of either age at first birth or age at menarche on melanoma risk. Our findings and the disparity in results between the previous studies suggest no large impact of reproductive and menstrual factors on melanoma risk. However, further studies are needed to draw definitive conclusions on the relation between number of live births and risk of melanoma.
Previous reports of oral contraceptives and malignant melanoma have predominantly failed to shown any association (Bain et al., 1982; Helmrich et al., 1984; Holman et al., 1984; Gallagher et al., 1985; Green and Bain, 1985; Osterlind et al., 1988b; Zanetti et al., 1990) . In some studies an increased risk has been observed for long duration of use (Beral et al., 1977 (Beral et al., , 1984 Adam et al., 1981; Holly et al., 1983; Hannaford et al., 1991; Le et al., 1992) or for use that started many years before diagnosis and lasted several years (Holly et al., 1983; Beral et al., 1984; Le et al., 1992 Le et al., 1992 ). In accordance with most studies (Beral et al., 1977; Adam et al., 1981; Bain et al., 1982; Helmrich et al., 1984; Holman et al., 1984; Gallagher et al., 1985; Green and Bain, 1985; 0sterlind et al., 1988b; Zanetti et al., 1990; Hannaford et al., 1991; Palmer et al., 1992) , our data on duration of oral contraceptive use and time when use took place, do not suggest a significant association between oral contraceptives and melanoma. However, hyperpigmentation during use of oral contraceptives and pregnancy typically occur in the face, but also around the breast and the umbilicus. Only a few studies have performed analyses of risk of site-specific melanoma in relation to oral contraceptive use (Beral et al., 1977 (Beral et al., , 1984 Zanetti et al., 1990) . In one study, with heterogeneous data, an excess of lesions of the lower limbs was reported (Beral et al., 1977) . In the present study, as in two other studies (Beral et al., 1984; Zanetti et al., 1990) , site-specific analyses (trunk vs extremeties or head and neck) did not show any difference from the overall results. Unfortunately, few, if any, of the studies (including ours) have been large enough to allow site-specific analyses to consider different sites more in detail.
As have others, we found no significant association between hormonal replacement therapy and melanoma risk (Beral et al., 1977 (Beral et al., , 1984 Adam et al., 1981; Holman et al., 1984; Gallagher et al., 1985; Osterlind et al., 1988b) .
To reduce the likelihood of selection bias, it was ascertained that all cases with a first diagnosis of melanoma within a defined area had been included and that controls were randomly selected from the general population of the same area. Furthermore, without knowing our hypothesis, a large percentage of cases and controls answered the comprehensive questionnaire. However, the response rate was somewhat higher for cases than for controls. It is difficult to assess fully the potential bias introduced by the differences in response rate between cases and controls, but there is no a priori reason to suspect that identified risk factors in this study are associated with non-participation.
One important methodological issue when performing a multivariate analysis is the issue of which variables to control for (see also above -prescribed drugs). Among possible confounders exposure to sunlight is the most important. The multivariate models included adjustments for number of sunburns as this factor was identified as the most important measure of sun exposure in this case -control study (Westerdahl et al., 1994a) . Analyses adjusted for other factors regarding sun exposure gave the same results. However, we cannot exclude that our findings could be due to uncontrolled confounding by a sun exposure variable and/ or another variable not measured in the questionnaire.
Another major source of bias in case-control studies is measurement errors. Although the self-administered questionnaire used in this case-control study has been shown to provide information with good test -retest reliability (Westerdahl et al., 1996) , the influence of non-differential misclassification may have been substantial, as stated above for prescribed drugs, as measures of exposures analysed were crude. In this context it is important to remember that our data on constitutional factors also relied on self-assessment.
However, it is widely appreciated that the effect of nondifferential misclassification is to lead to an underestimation of a true relationship. A particular concern in case-control studies is recall bias (i.e. if cases report differently than controls). In the present study identical procedures of data collection for cases and controls were used, the information from cases was collected close in time to the diagnosis in order to avoid the influence that the diagnosis of melanoma may have on recall, and subjects were unaware of our hypothesis. Furthermore, reported smoking habits, which are the object of health concern among the general population, were similar for cases and controls. We therefore do not think that misclassification because of reporting errors differs between cases and controls.
In conclusion, our results suggest that alcohol, smoking, reproductive or hormonal factors do not increase the risk of melanoma. However, increasing number of live births may be Drugs, alcohol, smoking, hormones and melanorna J Westerdahl et al % 1131 protective. Some support is lent to the possibility that specific types of prescribed drugs (beta-blockers. hydralazine and benzodiazepines) mav be associated wvith melanoma. However. these findings wvere diminished. at least for benzodiazepines. after adjustment for host factors and as they are unconfirmed. and may be due to chance or to confoundine. further investigation is needed.
